Benzinga's Top Pre-Market Losers

Loading...
Loading...
Cell Therapeutics
CTIC
shares fell 27.45% to $1.48 in the pre-market trading. Cell Therapeutics priced an underwritten public offering of 60,000 shares of its Series 17 Preferred Stock at a price of $1,000 per share. Zynga
ZNGA
shares dropped 22.91% to $2.17 in pre-market trading. Zynga cut its full-year forecast. Curtiss-Wright
CW
dipped 4.98% to $31.30 in the pre-market session. Curtiss-Wright lowered its 2012 profit forecast. Facebook
FB
dipped 2.77% to $21.34 in the pre-market session. Facebook's trailing-twelve-month profit margin is 13.34%.
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsTop Pre-Market Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...